{'fraction_non_alphanumeric': 0.01487603305785124, 'fraction_numerical': 0.005785123966942148, 'mean_word_length': 5.475935828877005, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Development of lymphocytic gastritis with recurrent Helicobacter pylori infection

CTX do not accumulate intracellularly, but CPFX does, and the cellular concentration is generally 4–10-fold larger than the extracellular concentration. Even though the use of CPFX in pediatric patients has been limited because of concerns regarding adverse musculoskeletal effects, CPFX may be considered appropriate in the treatment of Salmonella meningitis, for which the potential benefits outweigh the risks. The present patient did not relapse with Salmonella meningitis and did not develop any adverse musculoskeletal effects up to the age of 1. Because the data are inadequate to recommend dexamethasone to infants with Salmonella meningitis, the patient did not receive dexamethasone on the second admission. According to previous studies, two patients did not have relapse of Salmonella meningitis after the CSF was confirmed negative for Salmonella genomes on PCR. In the present case, although the CSF was negative for Salmonella genomes on PCR on days 8 and 35 in the first admission, Salmonella meningitis relapse did occur. Therefore, it may not be possible to anticipate Salmonella meningitis relapse using PCR.